Skip to content

Pfizer in talks over full license for COVID-19 vaccine in Singapore – Reuters

A medical worker prepares to dilute a vial of Pfizer-BioNTech vaccine at a coronavirus disease (COVID-19) vaccination center in Singapore March 8, 2021. REUTERS/Edgar Su
SINGAPORE, Sept 24 (Reuters) – Pfizer Inc (PFE.N) is in discussions with Singapore's Health Sciences Authority regarding obtaining a full license application for its COVID-19 vaccine, the company said in response to a query from Reuters.
Pfizer-BioNTech's (22UAy.DE) COVID-19 vaccine has interim authorisation under the pandemic special access route in Singapore. The U.S. Food and Drug Administration granted full approval to the vaccine last month. read more
Kenneth Mak, Singapore's director of medical services, said in a briefing on Friday Pfizer and Moderna (MRNA.O) had not submitted applications for full registration to authorities.
Singapore has not made COVID-19 vaccination compulsory, saying the Pfizer and Moderna shots only have emergency approval, although it has limited activities such as eating out for the unvaccinated.
Some experts say full registration could pave the way to make vaccination mandatory. read more
Our Standards: The Thomson Reuters Trust Principles.
Subscribe for our daily curated newsletter to receive the latest exclusive Reuters coverage delivered to your inbox.
New Zealand's Delta variant outbreak spread beyond the largest city of Auckland, prompting Prime Minister Jacinda Ardern on Sunday to put additional regions into a snap lockdown.
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world's media organizations, industry events and directly to consumers.
Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.
The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.
The industry leader for online information for tax, accounting and finance professionals.
Information, analytics and exclusive news on financial markets – delivered in an intuitive desktop and mobile interface.
Access to real-time, reference, and non-real time data in the cloud to power your enterprise.
Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2021 Reuters. All rights reserved

source

Leave a Reply

Your email address will not be published. Required fields are marked *